Relmada Therapeutics, Inc. ( RLMD) - Stock Earnings
RLMD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
RLMD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -19.9 million USD | — USD |
| 2026Q1 | -19.1 million USD | — USD |
| 2026Q2 | -12.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RLMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -98.8 million USD | — USD |
| 2024 | -80.0 million USD | — USD |
| 2025 | -57.4 million USD | — USD |
| 2026 Est. | — | — |
RLMD
Price: $3.10
52 week price:
Earnings Per Share: -0.91 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 144200
Market Capitalization: 365.0 million